0394
MRI-Based Response Prediction to Immunotherapy of Late-Stage Melanoma Patients Using Deep Learning
Annika Liebgott1,2, Louisa Fay1, Viet Chau Vu2, Bin Yang1, and Sergios Gatidis2
1Institute of Signal Processing and System Theory, University of Stuttgart, Stuttgart, Germany, 2Department of Radiology, University Hospital of Tuebingen, Tuebingen, Germany
Immunotherapy is a promising approach to treat advanced malignant melanoma. However, not every patient responds to it, i.e. in the worst case crucial time is wasted. Our research hence focuses on methods to early assess individual therapy response from PET/MR images using deep learning models.
Figure 3: Pipeline of our deep learning framework. Preprocessing of the data consists of organ segmentation, followed by data normalization and creation of TFRecords for efficient data processing, which are then split into training and test data and resized such that all images have the same size. The modular design allows to choose arbitrary deep learning models to investigate different network architectures. Dashed lines mark optional modules (data augmentation, transfer learning). As data augmentation, we implemented random rotation, random shift and elastic deformation9.
Figure 1: Exemplary abdominal slices of one examination: images with fat (a) and water weighted (b) Dixon sequences, ADC map (c) and PET image (d) were acquired. For each patient, examinations have been conducted prior to, two weeks and two months after starting immunotherapy.